CH633301A5 - Process for preparing novel 21-salicylic acid esters or 21-acetylsalicylic acid esters of steroids of the pregnane series - Google Patents
Process for preparing novel 21-salicylic acid esters or 21-acetylsalicylic acid esters of steroids of the pregnane series Download PDFInfo
- Publication number
- CH633301A5 CH633301A5 CH1632977A CH1632977A CH633301A5 CH 633301 A5 CH633301 A5 CH 633301A5 CH 1632977 A CH1632977 A CH 1632977A CH 1632977 A CH1632977 A CH 1632977A CH 633301 A5 CH633301 A5 CH 633301A5
- Authority
- CH
- Switzerland
- Prior art keywords
- acid esters
- prednisolone
- salicylate
- steroids
- salicylic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
- C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Pain & Pain Management (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB54510/76A GB1593978A (en) | 1976-12-31 | 1976-12-31 | Anti-inflammatory steroids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH633301A5 true CH633301A5 (en) | 1982-11-30 |
Family
ID=10471258
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH1632977A CH633301A5 (en) | 1976-12-31 | 1977-12-30 | Process for preparing novel 21-salicylic acid esters or 21-acetylsalicylic acid esters of steroids of the pregnane series |
Country Status (10)
| Country | Link |
|---|---|
| JP (1) | JPS53144561A (it) |
| BE (1) | BE862507A (it) |
| CH (1) | CH633301A5 (it) |
| DK (1) | DK155673C (it) |
| FI (1) | FI63422C (it) |
| FR (1) | FR2376160A1 (it) |
| GB (1) | GB1593978A (it) |
| NL (1) | NL7714482A (it) |
| NO (1) | NO148491C (it) |
| SE (1) | SE430607B (it) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1440063A (en) * | 1972-08-11 | 1976-06-23 | Glaxo Lab Ltd | 17alpha-esters of 17alpha,21-dihydroxy-20-oxo-steroids |
-
1976
- 1976-12-31 GB GB54510/76A patent/GB1593978A/en not_active Expired
-
1977
- 1977-12-27 FI FI773929A patent/FI63422C/fi not_active IP Right Cessation
- 1977-12-28 JP JP15754377A patent/JPS53144561A/ja active Granted
- 1977-12-28 NL NL7714482A patent/NL7714482A/xx not_active Application Discontinuation
- 1977-12-28 DK DK581677A patent/DK155673C/da not_active IP Right Cessation
- 1977-12-30 NO NO774525A patent/NO148491C/no unknown
- 1977-12-30 SE SE7714976A patent/SE430607B/sv unknown
- 1977-12-30 BE BE183990A patent/BE862507A/xx not_active IP Right Cessation
- 1977-12-30 FR FR7739817A patent/FR2376160A1/fr active Granted
- 1977-12-30 CH CH1632977A patent/CH633301A5/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| SE7714976L (sv) | 1978-07-02 |
| FR2376160B1 (it) | 1980-11-14 |
| JPS6220197B2 (it) | 1987-05-06 |
| FI773929A (fi) | 1978-07-01 |
| BE862507A (fr) | 1978-04-14 |
| FI63422B (fi) | 1983-02-28 |
| DK155673B (da) | 1989-05-01 |
| NO148491C (no) | 1983-10-19 |
| NO148491B (no) | 1983-07-11 |
| JPS53144561A (en) | 1978-12-15 |
| FR2376160A1 (fr) | 1978-07-28 |
| NL7714482A (nl) | 1978-07-04 |
| DK581677A (da) | 1978-07-01 |
| SE430607B (sv) | 1983-11-28 |
| FI63422C (fi) | 1983-06-10 |
| GB1593978A (en) | 1981-07-22 |
| DK155673C (da) | 1989-09-04 |
| NO774525L (no) | 1978-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0013376A2 (de) | Ein Isoxazolderivat, Verfahren zu seiner Herstellung und diese Verbindung enthaltende Mittel | |
| EP0011237A1 (de) | Polyäther-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | |
| EP0029247B1 (de) | Alkenyl-thienyl-alkancarbonsäuren und ihre Derivate, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel | |
| CH654287A5 (de) | Verbindungen und kompositionen zur reduktion der sebumsekretion. | |
| DE1668858B1 (de) | Betamethason-17-benzoat und dieses enthaltende Arzneimittel | |
| DE3717389A1 (de) | Neue naphthylaromatische verbindungen, verfahren zu ihrer herstellung und ihre verwendung in der human- und veterinaermedizin und in der kosmetik | |
| EP0100516B1 (de) | 3-Beta-(3'-(Carboxypropionyloxy))-ursa-9(11),12-dien-28-carbonsäure sowie ihre Salze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| DE2350148A1 (de) | Thiophenderivate, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen | |
| EP0009777B1 (de) | Retinsäure- und 7,8-Dehydro-retinsäure-N-(carboxy)-phenyl-amide, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel | |
| DE68915094T2 (de) | Benzofuranverbindungen, Verfahren zu ihrer Herstellung, diese enthaltende pharmazeutische und kosmetische Zusammenstellungen und Verwendung dieser Zusammenstellungen. | |
| DE2434929C2 (de) | p-Acetylaminophenolester von Phenylsalicylsäuren, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| DE2337067A1 (de) | Indensaeure-glucuronide | |
| DE2804293C2 (it) | ||
| DE3113149A1 (de) | 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaensaeure, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und ihre verwendung als antikrebsmittel und therapeutisches mittel fuer die behandlung von hauterkrankungen | |
| DE2328060A1 (de) | Benzo- eckige klammer auf b eckige klammer zu -thiophenderivate und verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate | |
| DE2318784A1 (de) | N-(2,4-dihydroxybenzoyl)-4-aminosalizylsaeure | |
| CH633301A5 (en) | Process for preparing novel 21-salicylic acid esters or 21-acetylsalicylic acid esters of steroids of the pregnane series | |
| DE1618536B1 (de) | Ester des d-Pantothenols und Verfahren zu deren Herstellung | |
| EP0147778A2 (de) | 1,4-Naphthochinonderivate mit entzündungshemmender Wirkung | |
| CH654316A5 (de) | 4-amino-1beta-d-ribofuranosyl-1h-imidazo(4,5-c)pyridin als mittel fuer die behandlung von entzuendungen. | |
| DE2759135A1 (de) | Neue steroidverbindungen und deren herstellung und verwendung | |
| DE1117571B (de) | Verfahren zur Herstellung von choleretisch wirksamer ª-[1-Hydroxy-4-phenylcyclohexyl-(1)]-buttersaeure, deren AEthylester bzw. deren Salzen | |
| EP0036992B1 (de) | Verwendung von S-Benzyl-3-benzylthiopropionthioat in Arzneimitteln | |
| EP0133318B1 (de) | Cycloaliphatische Aminosulfonsäurederivate, Verfahren zu deren Herstellung und Arzneimittel zur Bekämpfung von Herz- und Gefässkrankheiten | |
| DE1668858C (de) | Betamethason-17-benzoat und dieses enthaltende Arzneimittel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |